Costa Saroukos, Takeda CFO (Takeda)
Paying down more debt, Takeda offloads prescription drug portfolio for $562 million
It’s been two years since Takeda’s $62 billion Shire buyout, and the Tokyo biotech is still restructuring.
The company struck a deal with Germany …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
